Common Uses of Periactin (Cyproheptadine)
Periactin, the brand name for cyproheptadine, is a first‑generation antihistamine with additional antiserotonergic and anticholinergic activity. Clinically, it is used to relieve allergic symptoms such as sneezing, itchy or watery eyes, runny nose, and hives associated with allergic rhinitis and chronic urticaria. By blocking H1 receptors, it helps blunt histamine‑driven inflammation and itch, offering fast, effective relief for many patients who do not respond adequately to newer, non‑sedating antihistamines in both adults and children when appropriate and closely monitored.
Periactin is also used off‑label in select scenarios. Because it antagonizes serotonin receptors, clinicians may prescribe cyproheptadine to help prevent pediatric migraine, and in rare cases as part of treatment for serotonin toxicity under specialist supervision. Its appetite‑stimulating effect has led to off‑label use in underweight patients when reversible causes of poor intake have been evaluated; however, this should be considered only after careful medical assessment, as benefits must be weighed against sedation and anticholinergic adverse effects. As with any antihistamine, individual response varies, so patients should discuss goals, alternatives, and monitoring plans with a qualified healthcare professional before starting therapy.
Dosage and Directions for Periactin
For allergic rhinitis and urticaria in adults and adolescents, a common starting dose of Periactin (cyproheptadine) is 4 mg two to three times daily with food, titrated based on symptom control and tolerability. Some patients do well on 4 mg at bedtime plus 4 mg in the morning; others require 4 mg three times daily. The usual maximum is 32 mg per day in divided doses. Always use the lowest effective dose for the shortest necessary duration.
Pediatric dosing must be individualized. For children 2–6 years, many references suggest 2 mg two or three times daily (maximum 12 mg/day). For ages 7–14 years, 4 mg two or three times daily is typical (maximum 16 mg/day). Off‑label migraine prophylaxis regimens may be weight based (for example, 0.2–0.4 mg/kg/day in divided doses), but specialist guidance is advised. In all cases, caregivers should follow the prescriber’s instructions and reassess benefits and side effects regularly.
Take Periactin with a full glass of water and, if possible, at consistent times each day. Because drowsiness is common, many patients shift dosing toward evening or bedtime. Avoid alcohol and other sedatives. Do not exceed the prescribed amount, and do not use to treat acute asthma. If symptoms persist beyond a few days or worsen, contact your clinician promptly to adjust the plan or consider alternative allergy therapies.
Precautions and Safety Advice
Periactin can cause marked drowsiness, slowed reaction time, and blurred vision. Until you know your response, avoid driving, cycling, operating machinery, or tasks requiring alertness. Alcohol, cannabis, benzodiazepines, sleep medicines, and opioids can amplify sedation and respiratory depression; combining these increases risk for accidents and falls and injuries. Older adults are especially sensitive to anticholinergic effects and may experience confusion, constipation, and urinary retention. Use caution. Stay hydrated.
Use cyproheptadine cautiously if you have narrow‑angle glaucoma, prostatic hypertrophy or urinary tract obstruction, pyloroduodenal obstruction, severe constipation, cardiovascular disease, or hyperthyroidism. It may thicken bronchial secretions; people with chronic lung disease or asthma should consult a clinician before use when possible. Because cyproheptadine is hepatically metabolized, discuss dosing if you have liver impairment. During pregnancy or breastfeeding, weigh risks and benefits with your obstetrician or pediatrician.
Children and older adults can react unpredictably to first‑generation antihistamines. Paradoxical excitation, irritability, or insomnia may occur in pediatric patients, whereas delirium and falls are concerns in frail elders. Avoid use in premature infants and newborns. Limit sun exposure and use sunscreen, as photosensitivity can occur. This information is educational and not a substitute for personalized medical advice; always follow guidance from your prescribing clinician.
Contraindications to Cyproheptadine
Do not use Periactin if you have a known hypersensitivity to cyproheptadine or any tablet component. Cyproheptadine is contraindicated in newborn or premature infants, in breastfeeding mothers when risk outweighs benefit, and in patients with narrow‑angle glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, or pyloroduodenal obstruction due to its anticholinergic effects. It should not be used during an acute asthma attack.
Concomitant use with monoamine oxidase inhibitors (MAOIs) is generally contraindicated, as MAOIs can prolong and intensify anticholinergic and central nervous system effects. Individuals at risk for angle‑closure glaucoma should avoid cyproheptadine. Because first‑generation antihistamines can worsen confusion, many geriatric guidelines recommend avoiding them in older adults unless clearly necessary and carefully supervised. Please consult your pharmacist.
Possible Side Effects of Periactin
Common side effects of Periactin include drowsiness, fatigue, dizziness, dry mouth, blurred vision, constipation, and increased appetite with potential weight gain. Nausea or stomach upset can occur, especially early in treatment. Many effects lessen as the body adjusts, but persistent sedation or troublesome anticholinergic symptoms warrant dose reduction or a change to a less sedating, second‑generation antihistamine after discussing options with your clinician. Daytime impairment may persist if doses are scheduled too frequently or too early.
Less common effects include confusion, agitation, mood changes, restlessness, tremor, or difficulty urinating. Paradoxical stimulation can present as irritability or insomnia in children. In predisposed individuals, anticholinergic drugs may precipitate acute angle‑closure glaucoma or worsen constipation. If you notice severe dizziness, fainting, palpitations, rash, or swelling of the face or throat, stop the medicine and seek urgent medical care for possible hypersensitivity.
Rarely, cyproheptadine has been associated with liver test abnormalities or drug‑induced liver injury; contact your doctor if you develop persistent nausea, dark urine, pale stools, or yellowing of the skin or eyes. Photosensitivity reactions are possible; protect skin and eyes in bright sunlight. Report side effects to your healthcare professional and, in the U.S., to FDA MedWatch. Never share your medication with others, and keep a log of dose timing and symptoms to aid follow‑up. Bring that record to appointments for review.
Periactin Drug Interactions
Cyproheptadine’s sedative and anticholinergic properties interact additively with many medicines. Alcohol, benzodiazepines, sedative‑hypnotics, opioids, gabapentinoids, muscle relaxants, and some antipsychotics can markedly increase drowsiness, impaired coordination, and risk of falls or respiratory depression. Avoid combining with other strong anticholinergics, such as certain tricyclic antidepressants, antipsychotics, bladder antispasmodics, or antiparkinsonian agents, to limit confusion, constipation, dry mouth, and urinary retention. Monoamine oxidase inhibitors (MAOIs) can prolong and intensify cyproheptadine’s effects and are generally incompatible. Because it blocks serotonin receptors, Periactin may blunt the therapeutic effect of SSRIs, SNRIs, and triptans; do not use it to self‑treat mood disorders or migraines without guidance.
Antihistamines can suppress skin test reactivity; discontinue Periactin at least 72 hours before allergy skin testing if approved by your clinician. Herbal or over‑the‑counter products with sedating or anticholinergic effects (for example, diphenhydramine, doxylamine, kava, valerian, or motion‑sickness tablets) can compound adverse effects. While cyproheptadine has limited clinically significant CYP‑mediated interactions, always provide your pharmacist with a full medication list, including supplements, so they can screen for risks and optimize dosing, and monitor for cumulative sedation and confusion too.
Missed Dose: What to Do
If you miss a dose of Periactin, take it as soon as you remember unless it is close to the time for your next scheduled dose. If it is near the next dose, skip the missed dose and resume your regular dosing schedule. Do not double doses to catch up. To reduce missed doses, set reminders and align dosing with daily routines, such as after meals or at bedtime consistently.
Overdose: Signs and Immediate Actions
Overdose with cyproheptadine can produce pronounced anticholinergic toxicity and CNS effects. Warning signs include extreme drowsiness or agitation, hallucinations, confusion, flushed dry skin, dilated pupils, fever, vomiting, tremor, incoordination, rapid heartbeat, high blood pressure, urinary retention, and, in children, seizures. Severe cases may progress to coma or respiratory depression, especially when combined with alcohol, opioids, or benzodiazepines. Call emergency services immediately. Do not wait; act.
If an overdose is suspected, contact Poison Control (1‑800‑222‑1222 in the U.S.) or local emergency services right away. Do not induce vomiting unless instructed by professionals. Provide responders with the medication name, strength, amount taken, and timing. In the hospital, management may include activated charcoal, monitoring of heart rhythm and breathing, IV fluids, temperature control, and treatment of agitation or seizures. Bring the pill bottle.
Storage and Handling of Periactin
Store Periactin tablets at controlled room temperature, ideally 20–25°C (68–77°F), in a dry place away from direct light. Keep the bottle tightly closed and out of reach of children and pets. Do not store in bathrooms where humidity is high. Dispose of expired or unused medicine through take‑back programs or pharmacist‑approved disposal methods. Never decant into unlabeled containers when discarding.
U.S. Sale and Prescription Policy for Periactin
In the United States, Periactin (cyproheptadine) is a prescription‑only medication. Federal and state laws require a valid prescription from a licensed clinician to dispense it. Reputable pharmacies will verify prescriptions, screen for interactions, and provide counseling. Offers to sell prescription‑only antihistamines without a prescription are not compliant and may endanger your health, privacy, or financial security.
HealthSouth Rehabilitation Hospital of Manati supports safe, legal access by offering pharmacist guidance and, where available, connections to licensed telehealth providers who can evaluate your needs and issue a prescription if appropriate. This structured approach ensures proper diagnosis, dosing, and follow‑up while maintaining compliance with U.S. regulations. Check availability, pricing, and shipping options on our platform, and contact our team with any clinical or logistical questions.
